Searched for
RIBOCICLIB
Delhi HC seeks response on Natco's patent challenge pleaThe Delhi High Court is reviewing Natco Pharma's challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two pat...- Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
- Go on, pop the innovation pill: ₹5,000 cr push signals India’s shift from copy to createIndia's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr PRIP scheme a...
- Alembic Pharma gets tentative USFDA nod for breast cancer drugThe medicine is indicated for the treatment of adult patients with a certain type of advanced or metastatic breast cancer in a combination ...
- Breast cancer treatment successfully stops tumour growthMelbourne, July 28 (IANS) A breast cancer treatment developed by Australian researchers has successfully halted tumour growth for twice as ...
Load More